| __timestamp | Alkermes plc | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 447875000 | 117418000 |
| Thursday, January 1, 2015 | 483393000 | 102526000 |
| Friday, January 1, 2016 | 519270000 | 105386000 |
| Sunday, January 1, 2017 | 567637000 | 110188000 |
| Monday, January 1, 2018 | 601826000 | 121544000 |
| Tuesday, January 1, 2019 | 693218000 | 127930000 |
| Wednesday, January 1, 2020 | 572904000 | 148917000 |
| Friday, January 1, 2021 | 603913000 | 440760000 |
| Saturday, January 1, 2022 | 218108000 | 540517000 |
| Sunday, January 1, 2023 | 253037000 | 435577000 |
| Monday, January 1, 2024 | 245331000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, understanding cost dynamics is crucial. Jazz Pharmaceuticals plc and Alkermes plc, two prominent players, have shown intriguing trends in their cost of revenue from 2014 to 2023. Over this period, Alkermes plc's cost of revenue peaked in 2019, reaching approximately 693 million, before experiencing a significant drop of about 68% by 2022. In contrast, Jazz Pharmaceuticals plc demonstrated a steady increase, with a notable surge in 2022, where their cost of revenue rose by nearly 400% compared to 2014. This divergence highlights the strategic differences in managing production costs and market positioning. As the pharmaceutical industry continues to evolve, these insights provide a window into the financial strategies that drive success and sustainability.
GSK plc vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Alkermes plc
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated's Expenses
Jazz Pharmaceuticals plc vs Alkermes plc: A Gross Profit Performance Breakdown
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Veracyte, Inc.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and MiMedx Group, Inc.'s Expenses
Grifols, S.A. vs Alkermes plc: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Alkermes plc vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Trends: Alkermes plc vs Celldex Therapeutics, Inc.